Purchase Short-Term Access
In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone
Amy T. Wang, MD; Steven A. Smith, MD
Annals of Internal Medicine 2010;153:JC6-11.
doi:10.7326/0003-4819-153-12-201012210-02011
Purchase Online access to this article for 24 hours
